Stephen Lawrence Shiao MD PhD
Breast Cancer, Central Nervous System Cancer
Associate Professor
Join to View Full Profile
8700 Beverly BlvdCedars-Sinai Medical CenterLos Angeles, CA 90048
Phone+1 310-423-2836
Fax+1 310-659-3332
Dr. Shiao is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of California (San Francisco)Residency, Radiation Oncology, 2008 - 2012
Yale-New Haven Medical CenterInternship, Internal Medicine, 2007 - 2008
Yale School of MedicineClass of 2007
Certifications & Licensure
CA State Medical License 2009 - 2027
American Board of Radiology Radiation Oncology
Clinical Trials
- Novel Lung Imaging in Adults Undergoing Radiation Therapy to Assess for Radiation Pneumonitis Start of enrollment: 2016 Aug 21
- Dose Escalation Trial of Neoadjuvant Radiosurgery for the Treatment of Metastatic Brain Tumors Start of enrollment: 2017 May 09
- Breast Cancer Study of Preoperative Pembrolizumab + Radiation Start of enrollment: 2017 Dec 22
Publications & Presentations
PubMed
- Spatial transcriptomic analysis of immune checkpoint blockade response in triple negative breast cancers with tertiary lymphoid structures.Richard H Mebane, Teia Noel, Nathan Ing, Kenneth H Gouin 3rd, Aagam Shah
Iscience. 2025-07-18 - Prediction of Early Neoadjuvant Chemotherapy Response of Breast Cancer through Deep Learning-based Pharmacokinetic Quantification of DCE MRI.Chaowei Wu, Lixia Wang, Nan Wang, Stephen Shiao, Tai Dou
Radiology. Artificial Intelligence. 2025-07-09 - IL-17A-secreting γδ T cells promote resistance to CDK4/CDK6 inhibitors in HRHER2breast cancer via CX3CR1macrophages.Giulia Petroni, Claudia Galassi, Kenneth H Gouin 3rd, Hsiang-Han Chen, Aitziber Buqué
Nature Cancer. 2025-07-07
Journal Articles
- Comparison of Survival After Transoral Robotic Surgery vs Nonrobotic Surgery in Patients with Early-Stage Oropharyngeal Squamous Cell CarcinomaAnthony T Nguyen, Stephen L Shiao, Zachary S Zumsteg, JAMA Oncology
Authored Content
- Comparison of Survival After Transoral Robotic Surgery vs Nonrobotic Surgery in Patients with Early-Stage Oropharyngeal Squamous Cell CarcinomaAugust 2020
- Comparison of Survival After Transoral Robotic Surgery vs Nonrobotic Surgery in Patients with Early-Stage Oropharyngeal Squamous Cell CarcinomaAugust 2020
- Comparison of Survival After Transoral Robotic Surgery vs Nonrobotic Surgery in Patients with Early-Stage Oropharyngeal Squamous Cell CarcinomaAugust 2020
- Human Papillomavirus–Associated Oropharyngeal Cancer Among Patients Aged 70 and Older: Dramatically Increased Prevalence and Clinical ImplicationsOctober 2018
- Join now to see all
Press Mentions
Researchers Demonstrate How Tumors Make Immune Cells Less EffectiveJune 27th, 2022- Tumors Change Nearby Immune Cells to Promote Tumor GrowthJune 22nd, 2022
- Soft-Tissue Sarcomas Changes the Biology of Immune Cells Surrounding Tumors to Promote Tumor GrowthJune 22nd, 2022
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
